Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
801 On Other Exchanges
801 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

golden meditech holdings ltd (801) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China (PRC). It operates through five segments: Medical Devices, Cord Blood Storage, Hospital Management, Medical Insurance Administration, and Chinese Herbal Medicine. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment offers blood related medical devices comprising Autologous Blood Recovery System and its consumables; and distributes AXP System, an automated device for the process of extracting blood stem cells from cord blood. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The Hospital Management segment offers management services to hospitals. It also provides premium healthcare services; and operates two hospitals, which are specialized primarily in hematology. The Medical Insurance Administration segment offers medical insurance administration services. It provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

1,754 Employees
Last Reported Date: 11/28/14
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, C...
Total Annual Compensation: $6.6M
Chief Operating Officer and Executive Directo...
Total Annual Compensation: $6.6M
Qualified Accountant, Company Secretary and E...
Total Annual Compensation: $6.3M
Compensation as of Fiscal Year 2014.

golden meditech holdings ltd (801) Key Developments

Golden Meditech Holdings Limited Announces Board Changes

The board of directors of Golden Meditech Holdings Limited announced changes in Directors with effect from 11 February 2015. Mr. Lu Tian Long resigned as an executive Director due to his desire to devote more time to his personal endeavours. Mr. Daniel Foa was appointed as an independent non-executive Director and he will supervise the investment committee of the company. Mr. Daniel Foa, aged 38, is the co-founder of Fairklima Capital and has over 15 years of experience in the China market with expertise in the fields of technology, sustainability and business consulting. Before founding Fairklima Capital, Mr. Daniel Foa held managerial positions in major multinational firms. He is also the co-founder of 51Give, an online donations platform.

Golden Meditech Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2014

Golden Meditech Holdings Limited reported unaudited consolidated earnings results for the six months ended September 30, 2014. For the period, the company has reported turnover of HKD 546,011,000 compared to HKD 534,641,000 reported in the same period last year. The Group recorded operating profit of HKD 84,999,000, representing a 25.9% decrease as compared to HKD 114,637,000 reported in the corresponding period last year. Loss before taxation was HKD 71,678,000 against HKD 130,783,000 reported last year. During the reporting period, the Group recorded profit attributable to equity shareholders of the Company of HKD 1,433,000 or 0.08 cents per diluted share as compared to a loss of HKD 14,095,000 or 1.24 cents per diluted share in the previous reporting period. Net cash generated from operating activities was HKD 447,954,000 against HKD 410,822,000 reported last year. Payment for purchase of property, plant and equipment was HKD 132,971,000 against HKD 115,560,000 reported last year. Excluding such non-cash losses, adjusted profit attributable to equity shareholders of the Company was HKD 3,107,000 and HKD 26,226,000 for the current and previous reporting periods, respectively. The decrease in adjusted profit attributable to equity shareholders of the Company was in line with the decrease in operating profit.

Golden Meditech Holdings Limited to Report Q2, 2015 Results on Nov 28, 2014

Golden Meditech Holdings Limited announced that they will report Q2, 2015 results on Nov 28, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
801:HK $1.96 HKD +0.03

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies

Industry Analysis


Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.1x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at